Hidroxil (Thiamine Hydrochloride, Cyanocobalamin, Pyridoxine Hydrochloride)

Hidroxil is used to address conditions related to insufficient intake or increased demand for B‑vitamins.

• Prevention and correction of mild thiamine deficiency, which can affect carbohydrate metabolism.
• Management of vitamin B12 deficiency symptoms such as fatigue or peripheral neuropathy.
• Support for pyridoxine‑dependent enzymatic reactions, including amino‑acid metabolism.
• Adjunctive nutritional support for individuals with increased metabolic stress, such as athletes or pregnant persons.
• General supplementation to maintain normal nervous system function.
• Complementary use in dietary regimens for older adults to help sustain energy levels and cognitive health.

• The thiamine (vitamin B1) component functions as a coenzyme for pyruvate dehydrogenase and transketolase, facilitating carbohydrate decarboxylation and the pentose‑phosphate pathway. Cyanocobalamin (vitamin B12) is converted intracellularly to methylcobalamin and adenosylcobalamin, which serve as cofactors for methionine synthase and methylmalonyl‑CoA mutase, respectively, supporting DNA synthesis and fatty‑acid metabolism. Pyridoxine (vitamin B6) is phosphorylated to pyridoxal‑5′‑phosphate, a cofactor for aminotransferases and decarboxylases involved in amino‑acid and neurotransmitter synthesis.

Adverse reactions to Hidroxil are generally uncommon, but they can occur with any oral vitamin supplement. Most reported events are mild and self‑limiting, and they rarely lead to discontinuation of therapy.

Common

• Mild gastrointestinal discomfort such as nausea, abdominal fullness, or loose stools.
• Transient skin flushing or mild itching at the site of absorption.
• Headache or dizziness that resolves without intervention.
• Mild metallic taste in the mouth during or after ingestion.

Serious

• Allergic reactions including urticaria, angioedema, or respiratory difficulty.
• Severe cutaneous reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hematologic abnormalities like pancytopenia, though extremely rare.
• Anaphylactic shock requiring immediate medical attention, though it is exceedingly rare.

When considering Hidroxil, certain precautionary measures help ensure safe use, especially in specific population groups or health conditions.

• Assess for known hypersensitivity to any of the B‑vitamin components before initiating therapy.
• Use with caution in individuals with renal impairment, as excess water‑soluble vitamins may accumulate.
• Pregnant or breastfeeding persons should consult a healthcare professional to confirm appropriate supplementation.
• Patients with a history of gout should monitor uric acid levels, as high pyridoxine intake can influence metabolism.
• Avoid concurrent high‑dose vitamin B preparations to reduce risk of toxicity.
• Individuals on anticoagulant therapy should have INR monitored, given potential interaction with vitamin B12 metabolism.

Hidroxil may affect the pharmacokinetics or pharmacodynamics of certain medicines; awareness of these interactions supports optimal therapy.

Avoid

• Avoid simultaneous use with high‑dose oral metformin, as thiamine deficiency can exacerbate metformin‑associated lactic acidosis.
• Avoid co‑administration with isoniazid without thiamine supplementation, due to increased risk of peripheral neuropathy.

Use with caution

• Use with caution when taking antiepileptic drugs such as phenobarbital or carbamazepine, which can increase vitamin B6 metabolism.
• Use with caution in patients receiving chemotherapy agents that may cause folate or B‑vitamin depletion.
• Use with caution when combined with diuretics, particularly thiazides, which can increase urinary loss of water‑soluble vitamins.